Global Biosimilar Hormones Market Report 2021: Market is Expected to Reach $5.35 Billion in 2025 at a CAGR of 25% - Long-term Forecast to 2030
December 21, 2021 05:58 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Hormones Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
North America Biosimilars Market (2020 to 2030) - Trend Forecasts and Growth Opportunities
December 15, 2021 04:08 ET
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "North America Biosimilars Market 2020-2030 by Product Type, Indication, Manufacturing, End User, and Country: Trend Forecast and Growth Opportunity"...
Global Biosimilar Monoclonal Antibodies Market Report 2021: Market is Expected to Reach $10.92 Billion in 2025 at a CAGR of 26% with Long-term Forecast to 2030
December 09, 2021 05:23 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
The Worldwide Biosimilars Industry is Expected to Reach $44.7 Billion by 2026
November 09, 2021 07:53 ET
|
Research and Markets
Dublin, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab), Insulin, Interferon, Etanercept, Glucagon,...
Global $880 Million Pegfilgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
October 25, 2021 04:18 ET
|
Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
Global $1.04 Bn Filgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
October 20, 2021 04:13 ET
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
European Biosimilars Market Report 2021:Biosimilars for Cancers Accounts for > 20% Market
August 20, 2021 08:28 ET
|
Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Oral Biologics & Biosimilar Drugs Global Market Report 2021: Market is Expected to Reach $8.69 Billion in 2025 at a CAGR of 21% - Long-term Forecast to 2030
August 06, 2021 06:43 ET
|
Research and Markets
Dublin, Aug. 06, 2021 (GLOBE NEWSWIRE) -- The "Oral Biologics & Biosimilar Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
HUMIRA (Adalimumab) Biosimilars Market Report 2021: Current Developer Landscape and Clinical Research Scenario Related to All the Follow-on Products of the Blockbuster Biologic Drug
July 30, 2021 06:03 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "HUMIRA? (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
Global Rituximab Biosimilars Market Opportunities and Strategies Report 2021-2030: Focus on Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis
July 06, 2021 05:18 ET
|
Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Rituximab Biosimilars Global Market Opportunities and Strategies to 2030: COVID 19 Growth and Change" report has been added to ResearchAndMarkets.com's...